Brief: Erytech Pharma FY Operating Loss Widens To EUR 68.8 Mln

Phaxiam Therapeutics SA

09/03/2021 07:13

March 9 (Reuters) - Erytech Pharma  ERYP.PA :
    * REPORTED ON MONDAY FY OPERATING INCOME EUR 3.7 MLN VS EUR
5.3
MLN YR AGO
    * FY OPERATING LOSS EUR 68.8 MLN VS LOSS EUR 64.1 MLN YR AGO
    * FY NET LOSS EUR 73.3 MLN VS LOSS EUR 62.7 MLN YR AGO
    * AS OF DEC 31, 2020, CO HAD CASH AND CASH EQUIVALENTS
TOTALING
EUR 44.4 MLN VS EUR 73.2 MLN ON DEC 31, 2019 AND EUR 45.4 MLN ON
JUNE 30, 2020
    * CO SAYS ITS CURRENT CASH POSITION CAN FUND ITS PLANNED
OPERATING
EXPENSES AND CURRENT PROGRAMS INTO Q4 2021 AND TOGETHER WITH
REMAINING OPTION OF POTENTIAL PROCEEDS AVAILABLE UNDER
CONVERTIBLE BONDS FINANCING AGREEMENT INTO Q1 2022

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNX5FjlWt
    
 Further company coverage:  ERYP.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))